GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sotac Pharmaceuticals SOTAC.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

130.00

—

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Sotac Pharmaceuticals — daily BSE:SOTAC End of day BSE listing — our prices are the NSE line

Why two exchanges. Sotac Pharmaceuticals trades on both NSE and BSE. TradingView's free charts don't carry NSE, so the chart shows the BSE listing. The ticker and close we quote are the NSE line.

Market value
₹1.44bn
Last close × shares
Volume
1.2k
Shares, 9 Nov 2026
Price to earnings
15.5
Dividend yield
0.08%

About Sotac Pharmaceuticals

Its shares trade on NSE under the ticker SOTAC.NS. It has been listed since 13 April 2023. In the fiscal year to 31 March 2025, it reported revenue of ₹969.9m and net income of ₹80.3m. At that date it held total assets of ₹1.24bn and shareholders' equity of ₹532.5m.

Sotac Pharmaceuticals Ltd. engages in developing and manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2023-04-13. The firm specializes in the manufacturing of a range of pharmaceutical products, such as Non Beta-Lactam (general) tablets, Non Beta-Lactam (general) capsules, Non Beta-Lactam syrup, and external preparations. The company is engaged in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis. Its therapeutic portfolio includes Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, AntiAllergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, AntiPyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams and Non-IP-Lactams, Anti-Fungal, and Cephalosporin. Its subsidiaries include SOTAC Healthcare Private Limited (SOTAC Healthcare), SOTAC Research Private Limited (SOTAC Research), and SOTAC Lifescience Private Limited.

Figures and description from our data supplier, not checked against the company's own report.

More about Sotac Pharmaceuticals →

Latest on Sotac Pharmaceuticals

Our reporting

We have not reported on Sotac Pharmaceuticals yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Sotac Pharmaceuticals's ticker?

Sotac Pharmaceuticals trades as SOTAC.NS on NSE, under ISIN INE0O2D01012.

What was Sotac Pharmaceuticals's last closing price?

130.00 on 9 Nov 2026. The figure is in INR and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.